Unknown

Dataset Information

One single method to produce native and Tat-fused recombinant human α-synuclein in Escherichia coli.


ABSTRACT:

Background

Human α-synuclein is a small-sized, natively unfolded protein that in fibrillar form is the primary component of Lewy bodies, the pathological hallmark of Parkinson's disease. Experimental evidence suggests that α-synuclein aggregation is the key event that triggers neurotoxicity although additional findings have proposed a protective role of α-synuclein against oxidative stress. One way to address the mechanism of this protective action is to evaluate α-synuclein-mediated protection by delivering this protein inside cells using a chimeric protein fused with the Tat-transduction domain of HIV Tat, named TAT-α-synuclein.

Results

A reliable protocol was designed to efficiently express and purify two different forms of human α-synuclein. The synthetic cDNAs encoding

SUBMITTER: Caldinelli L 

PROVIDER: S-EPMC3621789 | biostudies-literature | 2013 Apr

REPOSITORIES: biostudies-literature